Valrubicin
生产企业:Endo pharmaceutical solutions inc
Valrubicin is an anthracycline used intravesically in the treatment of BCG-resistant bladder carcinoma.
Valrubicin is an anthracycline used intravesically in the treatment of BCG-resistant bladder carcinoma.
Valrubicin is an anthracycline that affects a variety of inter-related biological functions, most of which involve nucleic acid metabolism. It readily penetrates into cells, where after DNA intercalation, it inhibits the incorporation of nucleosides into nucleic acids, causes extensive chromosomal damage, and arrests cell cycle in G2. Although valrubicin does not bind strongly to DNA, a principal mechanism of its action, mediated by valrubicin metabolites, is interference with the normal DNA breaking-resealing action of DNA topoisomerase II.
For the treatment of cancer of the bladder.
共 1 项相关疾病
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。